tirzepatide surpass 2 Once Weekly in Children and Adolescents with Type Diabetes ( SURPASS-Peds). The New England Journal of Medicine. 2024;391:XXX–XXX. doi:10.1056/NEJMoa2400938 Patient-Reported Outcomes in People with

Data were analysed by: two-tailed Students unpaired t-test ( a, b, c, d, e, i, j, k, l, m )

Most patients report eating smaller portions and experiencing less frequent food cravings, though scale weight may not shift significantly during this period due to normal fluid and glycogen fluctuations

They can advise on proper dosing and any interactions

The aggregated results show structural and biomechanical improvements in four tissues: muscle, tendon, ligament, and bone

Novo Nordisk reports that patients with insurance coverage typically pay $25 or less monthly when the medication is covered by their plan

& Clment, B